Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $325.0000 (3.17%) ($315.0000 - $325.0000) on Wed. Aug. 31, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.82% (three month average) | RSI | 39 | Latest Price | $325.0000(3.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(4%) PEJ(4%) EWP(3%) XOP(3%) EWI(2%) | Factors Impacting CAPR price | CAPR will decline at least -2.41% in a week (0% probabilities). REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.41% (StdDev 4.82%) | Hourly BBV | 0 () | Intraday Trend | 3.2% | | | |
|
1 - 5 Day Possible Target | $301.96(-7.09%) | 5 Day Moving Average | $313.3(3.73%) | 10 Day Moving Average | $314.73(3.26%) | 20 Day Moving Average | $322.68(0.72%) | To recent high | -18.8% | To recent low | 12.1% | Market Cap | $6.402b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |